Strategic workshops on cancer nanotechnology.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 20460532.
- Also identified by DOI 10.1158/0008-5472.CAN-09-3716 and PMC identifier 2880215.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nanotechnology offers the potential for new approaches to detecting, treating, and preventing cancer. To determine the current status of the cancer nanotechnology field and the optimal path forward, the National Cancer Institute's Alliance for Nanotechnology in Cancer held three strategic workshops, covering the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. At each of these meetings, a wide range of experts from academia, industry, the nonprofit sector, and the U.S. government discussed opportunities in the field of cancer nanotechnology and barriers to its implementation.
Medical subject headings
- Nanotechnology
- Neoplasms